Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

20

Revenue 2017

Triumeq

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Triumeq was produced by GlaxoSmithKline.

CDC backs GSK’s Shingrix over Merck & Co’s Zostavax

CDC backs GSK’s Shingrix over Merck & Co’s Zostavax Once again HIV therapies Tivicay (dolutegravir) and Triumeq (dolutegravir, abacavir and lamivudine) - up 45% to £1.47bn - led the advance amongst GSK’s prescription pharma business, with support from new asthma

ViiV files two-drug HIV maintenance regimen

ViiV files two-drug HIV maintenance regimen s fast-growing Triumeq (dolutegravir, abacavir and lamivudine) but not - as it had hoped - a superior profile. ... With Triumeq likely to feel the pinch ViiV will be hoping its emphasis on two-drug regimens could keep it on a competitive footing.

Gilead plans fightback against HIV arch-rival ViiV

Gilead plans fightback against HIV arch-rival ViiV Descovy sees phase III success after the TAF-based drug proves non-inferior to Triumeq. ... Triumeq, which contains rival integrase Tivicay (dolutegravir) as well as abacavir and lamivudine.

GSK's Witty ends on a high, but warns 2017 looking 'uncertain'

GSK's Witty ends on a high, but warns 2017 looking 'uncertain' and Triumeq (dolutegravir/abacavir/lamivudine).

ViiV takes two-drug cocktail for first-line HIV into phase III

ViiV takes two-drug cocktail for first-line HIV into phase III HIV therapies that combine multiple drugs into one tablet such as ViiV's Triumeq (dolutegravir/abacavir/lamivudine) and Gilead's Quad product (elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide) are expected to be

[ Previous 5 results ] 1 2 3 4 5 6 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics